No Detail Found!

Azathioprine vs. Methotrexate Effectiveness in the Treatment of Generalized Myasthenia Gravis (MG)

Author(s)
Sadaf Iftikhar Department of Neurology, King Edward Medical University (KEMU), Mayo Hospital,Lahore,Pakistan
Asfand Kousar Department of Neurology, King Edward Medical University (KEMU), Mayo Hospital,Lahore,Pakistan
Aysha Ghayyur Department of Medicine, Allama Iqbal Medical College (AIMC), Jinnah Hospital,Lahore,Pakistan
Saman Shahid Department of Sciences & Humanities, National University of Computer & Emerging Sciences (NUCES), FAST Lahore Campus,Lahore,Pakistan
Adina Qaiser Department of Physiology, Khawaja Safdar Medical College,Sialkot,Pakistan
Abstract
Objective: The current study investigated the effectiveness of Azathioprine versus Methotrexate in the treatment of generalized MG. Materials & Methods: An observational, open-label retrospective study was conducted in the Department of Neurology, Mayo Hospital, Lahore, Pakistan. All generalized MG patients with positive acetylcholine receptor antibodies (MGFA class II, III, or IV) aged =16 years, were included. Group 1 (n=31) was taking the combination of oral Prednisolone and Azathioprine (AZA) and group 2 (n=31) was taking the combination of Prednisolone and Methotrexate (MTX). The clinical response was assessed by Myasthenia gravis activities of daily living (MGADL) score at the 3rd, 6th, 9th, 12th, & 18th months. Results: At 3rd-month follow-up, the mean MG-ADL score was 2.97 (AZA) vs. 3.39 (MTX), after the 6th month, the score was 0.48(AZA) vs. 1.13 (MTX) (p-value=0.009), after the 9th month: the score was 0.26 (AZA), vs. 0.97(MTX) (p-value=0.002), after the 12th month, the score was 0.29 (AZA) vs. 0.74 (MTX) (p-value=0.079), after 15th month, the score was 0.16(AZA) vs. 0.65(MTX) (p-value=0.009) and after 18th month, the score was 0.42(AZA) vs. 0.52(MTX) (p-value=0.703). Conclusion: Azathioprine is significantly more efficacious from the 6th, 9th, 12th and after the 15th-month followup as compared to Methotrexate in the treatment of MG; however, on the 18th-month follow-up, both steroidsparing drugs were equally effective. There appears to be no difference in the effectiveness of Azathioprine versus Methotrexate in the treatment of generalized MG.
Publication Details
Page(s) 192-201
Published Journal: Pakistan Journal of Neurological Surgery, Volume: 28, Issue: 2, Year: 2024

Request the full text from PASTIC

Keywords
Methotrexate, azathioprine, Generalized Myasthenia Gravis, Myasthenia Gravis Foundation of America (MGFA)
0

Citations

0

Downloads

29

Views